@ARTICLE{
author={Oh Jiwon,Drulovic Jelena S,Dufek Michal,Budincevic Hrvoje,Habek Mario,Caunt Maresa,Cheng Ying-Fang,Harp Christopher,Sierzega Malgorzata,Clayton David,Ratchford John,Goodyear Alexandra,Bar-Or Amit},
year={2025},
title={Fenebrutinib maintains early and sustained low disease activity in patients with relapsing multiple sclerosis: 2-year results from the FENopta open-label extension},
journal={MULTIPLE SCLEROSIS JOURNAL},
volume={31},
number={3},
pages={109-109},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Bar-Or Amit,Oh J,Dufek Michal,Budincevic Hrvoje,Habek Mario,Caunt Maresa,Harp C,Sierzega M,Clayton David,Chen Y,Ratchford JN,Goodyear Alexandra,Drulovic Jelena S},
year={2025},
title={Fenebrutinib Maintains Low Disease Activity in Relapsing Multiple Sclerosis: Clinical, Safety and Biomarker Results From the FENopta Open-Label Extension},
journal={MULTIPLE SCLEROSIS JOURNAL},
volume={31},
number={2_SUPPL},
pages={244-244},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Bar-Or Amit,Oh Jiwon,Dufek Michal,Budincevic Hrvoje,Habek Mario,Caunt Maresa,Thomas Piia,Sierzega Malgorzata,Clayton David,Cheng Ying Fang,Ratchford John,Goodyear Alexandra,Drulovic Jelena S},
year={2024},
title={Fenebrutinib maintains low disease activity in relapsing multiple sclerosis: results from the FENopta trial open-label extension},
journal={MULTIPLE SCLEROSIS JOURNAL},
volume={30},
number={3},
pages={1021-1022},
document_type={Meeting Abstract},
}